Table 1 Patient Demographics: Characteristics of pregnant patients exposed to OnabotulinumtoxinA
From: OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
|  | All (N = 45) | Continue onabotulinumtoxinA (N = 32) | Stopped onabotulinumtoxinA (N = 13) |
|---|---|---|---|
Age | 30.9 (19–42) | 29.8 (19–36) | 33.3 (21–42) |
Migraine Onset | 14.4 (8–23) | 14.5 (8–23) | 14.2 (8–23) |
CM Duration | 3.7 (0.5–10) | 3.6 (0.5–10) | 3.8 (1–8) |